Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z

CDC Media Relations
Media Home | Contact Us
US Department of Health and Human Services logo and link

Media Relations Links
About Us
Media Contact
Frequently Asked Questions
Media Site Map

CDC News
Press Release Library
Transcripts
MMWR Summaries
B-Roll Footage
Upcoming Events

Related Links
Centers at CDC
Data and Statistics
Health Topics A-Z
Image Library
Publications, Software and Other Products
Global Health Odyssey
Find your state or local health department
HHS News
National Health Observances
Visit the FirstGov Web Site
Div. of Media Relations
1600 Clifton Road
MS D-14
Atlanta, GA 30333
(404) 639-3286
Fax (404) 639-7394

 

Press Release

For Immediate Release:
June 7, 2004
Contact: CDC Media Relations
404-639-3286

CDC Collaboration Yields New Test for Anthrax

A new test funded by the Centers for Disease Control and Prevention and developed in collaboration with a commercial partner has become the first test approved by the Food and Drug Administration for detecting antibodies to anthrax. The test, produced by Immunetics Inc. of Boston, provides an easy-to-use clinical laboratory tool for assessing whether patients have been infected with anthrax.

The Anthrax Quick ELISA test, which was recently approved by the Food and Drug Administration, detects antibodies produced during infection with Bacillus anthracis – the bacteria that causes anthrax. The approval shows how cooperative work between government agencies and industry can lead to the development of diagnostic tests for biothreat agents and emerging infectious diseases.

The new test helps confirm a diagnosis of anthrax because it demonstrates that a person’s immune system has responded to a protein produced by the infecting bacteria. The test is quicker and easier to interpret than previous antibody testing methods. The new test can be completed in less than one hour, compared to about four hours for previous testing methods. Before FDA approval of the new test, very few laboratories other than the CDC and the U.S. Army had the ability to test blood for antibodies to anthrax. The new test will be available shortly for use in state and private laboratories.

Anthrax is a serious infectious disease that most commonly occurs in wild and domestic cattle, sheep and other herbivores. Humans can contract anthrax by handling products from infected animals or by breathing in or coming in close contact with Bacillus anthracis spores from infected animal products such as unprocessed hides and bones. Anthrax can also be transmitted to humans when anthrax spores are used as a bioterrorist weapon. The anthrax attacks of 2001 sickened 22 people, leading to five deaths.


Media Home Page | Accessibility | Privacy Policy | Contact Us
CDC Home | Search | Health Topics A-Z

This page last updated June 7, 2004
URL: http://www.cdc.gov/media/pressrel/r040607.htm

United States Department of Health and Human Services
Centers for Disease Control and Prevention
Office of Communication
Division of Media Relations